Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Cancer Res ; 25(24): 7554-7564, 2019 12 15.
Article in English | MEDLINE | ID: mdl-31455682

ABSTRACT

PURPOSE: Immunotherapy with IL2, GM-CSF, and an anti-disialoganglioside (GD2) antibody significantly increases event-free survival in children with high-risk neuroblastoma. However, therapy failure in one third of these patients and IL2-related toxicities pose a major challenge. We compared the immunoadjuvant effects of IL15 with those of IL2 for enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) in neuroblastoma. EXPERIMENTAL DESIGN: We tested ADCC against neuroblastoma patient-derived xenografts (PDX) in vitro and in vivo and examined the functional and migratory properties of NK cells activated with IL2 and IL15. RESULTS: In cell culture, IL15-activated NK cells induced higher ADCC against two GD+ neuroblastoma PDXs than did IL2-activated NK cells (P < 0.001). This effect was dose-dependent (P < 0.001) and was maintained across several effector-to-tumor ratios. As compared with IL2, IL15 also improved chemotaxis of NK cells, leading to higher numbers of tumorsphere-infiltrating NK cells in vitro (P = 0.002). In an orthotopic PDX model, animals receiving chemoimmunotherapy with an anti-GD2 antibody, GM-CSF, and a soluble IL15/IL15Rα complex had greater tumor regression than did those receiving chemotherapy alone (P = 0.012) or combined with anti-GD2 antibody and GM-CSF with (P = 0.016) or without IL2 (P = 0.035). This was most likely due to lower numbers of immature tumor-infiltrating NK cells (DX5+CD27+) after IL15/IL15Rα administration (P = 0.029) and transcriptional upregulation of Gzmd. CONCLUSIONS: The substitution of IL15 for IL2 leads to significant tumor regression in vitro and in vivo and supports clinical testing of IL15 for immunotherapy in pediatric neuroblastoma.


Subject(s)
Antibodies, Monoclonal/immunology , Antibody-Dependent Cell Cytotoxicity/immunology , Immunotherapy/methods , Interleukin-15/immunology , Killer Cells, Natural/immunology , Neuroblastoma/pathology , Animals , Antibodies, Monoclonal/administration & dosage , Child , Female , Gangliosides/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Humans , Interleukin-2/immunology , Neuroblastoma/immunology , Neuroblastoma/therapy , Xenograft Model Antitumor Assays
2.
Development ; 143(24): 4608-4619, 2016 12 15.
Article in English | MEDLINE | ID: mdl-27827819

ABSTRACT

During embryonic development, undifferentiated progenitor cells balance the generation of additional progenitor cells with differentiation. Within the developing limb, cartilage cells differentiate from mesodermal progenitors in an ordered process that results in the specification of the correct number of appropriately sized skeletal elements. The internal pathways by which these cells maintain an undifferentiated state while preserving their capacity to differentiate is unknown. Here, we report that the arginine methyltransferase PRMT5 has a crucial role in maintaining progenitor cells. Mouse embryonic buds lacking PRMT5 have severely truncated bones with wispy digits lacking joints. This novel phenotype is caused by widespread cell death that includes mesodermal progenitor cells that have begun to precociously differentiate into cartilage cells. We propose that PRMT5 maintains progenitor cells through its regulation of Bmp4 Intriguingly, adult and embryonic stem cells also require PRMT5 for maintaining pluripotency, suggesting that similar mechanisms might regulate lineage-restricted progenitor cells during organogenesis.


Subject(s)
Cartilage/cytology , Chondrogenesis/genetics , Embryonic Stem Cells/metabolism , Forelimb/embryology , Limb Buds/embryology , Protein-Arginine N-Methyltransferases/genetics , Animals , Apoptosis/genetics , Bone Morphogenetic Protein 4/metabolism , Cells, Cultured , Embryonic Stem Cells/cytology , Forelimb/abnormalities , Mesoderm/cytology , Mesoderm/metabolism , Mice , Mice, Knockout , SOX9 Transcription Factor/metabolism , Signal Transduction/genetics
3.
Nat Commun ; 7: 12903, 2016 10 07.
Article in English | MEDLINE | ID: mdl-27713395

ABSTRACT

The number of phalanges and joints are key features of digit 'identity' and are central to limb functionality and evolutionary adaptation. Prior chick work indicated that digit phalanges and their associated joints arise in a different manner than the more sparsely jointed long bones, and their identity is regulated by differential signalling from adjacent interdigits. Currently, there is no genetic evidence for this model, and the molecular mechanisms governing digit joint specification remain poorly understood. Using genetic approaches in mouse, here we show that functional 5'Hoxd-Gli3 antagonism acts indirectly, through Bmp signalling from the interdigital mesenchyme, to regulate specification of joint progenitors, which arise in conjunction with phalangeal precursors at the digit tip. Phalanx number, although co-regulated, can be uncoupled from joint specification. We propose that 5'Hoxd genes and Gli3 are part of an interdigital signalling centre that sets net Bmp signalling levels from different interdigits to coordinately regulate phalanx and joint formation.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Extremities/embryology , Homeodomain Proteins/physiology , Joints/embryology , Nerve Tissue Proteins/physiology , Zinc Finger Protein Gli3/physiology , Animals , Carrier Proteins/metabolism , Gene Dosage , Gene Knock-In Techniques , Joints/metabolism , Mice , Phenotype
4.
Development ; 143(11): 2000-11, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27122171

ABSTRACT

The endodermal pouches are a series of reiterated structures that segment the pharyngeal arches and help pattern the vertebrate face. Multiple pathways regulate the complex process of endodermal development, including the Bone morphogenetic protein (Bmp) pathway. However, the role of Bmp signaling in pouch morphogenesis is poorly understood. Using genetic and chemical inhibitor approaches, we show that pouch morphogenesis requires Bmp signaling from 10-18 h post-fertilization, immediately following gastrulation. Blocking Bmp signaling during this window results in morphological defects to the pouches and craniofacial skeleton. Using genetic chimeras we show that Bmp signals directly to the endoderm for proper morphogenesis. Time-lapse imaging and analysis of reporter transgenics show that Bmp signaling is necessary for pouch outpocketing via the Fibroblast growth factor (Fgf) pathway. Double loss-of-function analyses demonstrate that Bmp and Fgf signaling interact synergistically in craniofacial development. Collectively, our analyses shed light on the tissue and signaling interactions that regulate development of the vertebrate face.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Endoderm/embryology , Fibroblast Growth Factors/metabolism , Morphogenesis , Signal Transduction , Zebrafish/embryology , Zebrafish/metabolism , Animals , Cell Count , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Endoderm/drug effects , Endoderm/metabolism , Face/embryology , Morphogenesis/drug effects , Neural Crest/drug effects , Neural Crest/metabolism , Neural Crest/pathology , Pyrazoles/pharmacology , Pyrimidines/pharmacology , Signal Transduction/drug effects , Skull/drug effects , Skull/pathology , Time Factors
5.
Dev Biol ; 393(2): 270-281, 2014 Sep 15.
Article in English | MEDLINE | ID: mdl-25034710

ABSTRACT

Mutations in the Bone Morphogenetic Protein (BMP) pathway are associated with a range of defects in skeletal formation. Genetic analysis of BMP signaling requirements is complicated by the presence of three partially redundant BMPs that are required for multiple stages of limb development. We generated an inducible allele of a BMP inhibitor, Gremlin, which reduces BMP signaling. We show that BMPs act in a dose and time dependent manner in which early reduction of BMPs result in digit loss, while inhibiting overall BMP signaling between E10.5 and E11.5 allows polydactylous digit formation. During this period, inhibiting BMPs extends the duration of FGF signaling. Sox9 is initially expressed in normal digit ray domains but at reduced levels that correlate with the reduction in BMP signaling. The persistence of elevated FGF signaling likely promotes cell proliferation and survival, inhibiting the activation of Sox9 and secondarily, inhibiting the differentiation of Sox9-expressing chondrocytes. Our results provide new insights into the timing and clarify the mechanisms underlying BMP signaling during digit morphogenesis.


Subject(s)
Bone Morphogenetic Protein 2/genetics , Bone Morphogenetic Protein 4/genetics , Bone Morphogenetic Protein 7/genetics , Limb Buds/embryology , Polydactyly/genetics , Animals , Apoptosis , Bone Morphogenetic Protein 2/antagonists & inhibitors , Bone Morphogenetic Protein 4/antagonists & inhibitors , Bone Morphogenetic Protein 7/antagonists & inhibitors , Bone Morphogenetic Proteins/antagonists & inhibitors , Bone Morphogenetic Proteins/genetics , Cell Differentiation/genetics , Cell Proliferation , Chondrogenesis/genetics , Cytokines , Fibroblast Growth Factors/metabolism , Gene Expression Regulation, Developmental , Hindlimb/embryology , Intercellular Signaling Peptides and Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins/genetics , Mesoderm/embryology , Mice , Mice, Transgenic , Mutation , Polydactyly/embryology , SOX9 Transcription Factor/biosynthesis , Signal Transduction/genetics
6.
Development ; 141(9): 1906-14, 2014 May.
Article in English | MEDLINE | ID: mdl-24700818

ABSTRACT

The transcriptional response to the Hedgehog (Hh) pathway is mediated by Gli proteins, which function as context-dependent transcriptional activators or repressors. However, the mechanism by which Gli proteins regulate their target genes is poorly understood. Here, we have performed the first genetic characterization of a Gli-dependent cis-regulatory module (CRM), focusing on its regulation of Grem1 in the mouse limb bud. The CRM, termed GRE1 (Gli responsive element 1), can act as both an enhancer and a silencer. The enhancer activity requires sustained Hh signaling. As a Gli-dependent silencer, GRE1 prevents ectopic transcription of Grem1 driven through additional CRMs. In doing so, GRE1 works with additional GREs to robustly regulate Grem1. We suggest that multiple Gli CRMs may be a general mechanism for mediating a robust transcriptional response to the Hh pathway.


Subject(s)
Intercellular Signaling Peptides and Proteins/genetics , Kruppel-Like Transcription Factors/metabolism , Limb Buds/embryology , Limb Buds/metabolism , Repressor Proteins/metabolism , Vertebrates/embryology , Vertebrates/genetics , Animals , Cytokines , Enhancer Elements, Genetic/genetics , Gene Expression Regulation, Developmental , Hedgehog Proteins/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Mice , Models, Biological , Signal Transduction/genetics , Time Factors , Zinc Finger Protein GLI1
SELECTION OF CITATIONS
SEARCH DETAIL
...